According to a new report by IntelMarketResearch, the global Pneumonia Vaccine Market was valued at approximately USD 7.85 billion in 2025 and is projected to reach USD 12.67 billion by 2034, expanding at a CAGR of 5.3% during the forecast period from 2025 to 2034.
Pneumonia vaccines are biological preparations designed to stimulate immunity against Streptococcus pneumoniae and related...